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The objective of this study was to produce encapsulated protein hydrolysates from Whitemouth croaker
(Micropogonias furnieri) muscle and its industrialization byproduct. The protein hydrolysates were pre-
pared from the muscle (MPH) and byproduct (BPH) from croaker by enzymatic hydrolysis using Fla-
vourzyme. The hydrolysates were encapsulated using phosphatidylcholine as the wall material of the
capsules. The capsules were evaluated for particle size, polydispersity, encapsulation efﬁciency, zeta
potential, morphology, thermal properties, Fourier transform infrared (FTIR) spectroscopy and antioxi-
dant activity. The average size of the capsules for both MPH and BPH liposomes range between 266 and
263 nm with low polydispersity. The capsules showed high encapsulation efﬁciency of around 80%. The
FTIR analysis allowed suggesting that there was an effective ionic complexation between phosphati-
dylcholine and hydrolysate peptides. The antioxidant activity of the hydrolysates and capsules containing
MPH and BPH was similar to the activity of a-tocoferol, but lower than that of vitamin C.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Enzymatic hydrolysis proteins are an efﬁcient way to produce
potent bioactive peptides (Thiansilakul, Benjakul, & Shahidi, 2007).
Various food protein sources including ﬁsh, milk, egg, soybean,
wheat and zein, among others, have been exploited to produce
antioxidative protein hydrolysates and peptides (Samaranayaka &
Li-Chan, 2011). Protein hydrolysates are breakdown products of
enzymatic conversion of proteins into smaller peptides. Generally,
protein hydrolysates are small fragments of peptides that contain
2e20 amino acids. These protein hydrolysates are produced by the
enzymatic hydrolysis of native proteins. Protein hydrolysis de-
creases peptide size, thereby making hydrolysates the mostnce and Technology, Federal
ax: þ55 53 32338621.
Rosa Zavareze).available amino acid source for various physiological functions of
the human body (Neklyudov, Ivankin, & Berdutina, 2000).
Proteins are sources of bioactive peptides that are inactive and
are activated during the digestive process or during food process-
ing. Once released, peptides exert diverse physiological functions
such as anti-ulcer, anticarcinogenic, antihypertensive, and antiox-
idant activity (Korhonen & Pihlanto, 2003). Antioxidant activity is
associated with certain peptides present in protein sequences,
released after enzymatic hydrolysis. Antioxidants are compounds
that can act as hydrogen donors, stabilizing free radicals that are
formed naturally in cell metabolism and are responsible for many
degenerative diseases such as cardiovascular diseases, diabetes,
and Alzheimer’s disease (Chanput, Theerakulkait, & Nakai, 2009;
Harnedy & FitzGerald, 2012).
The antioxidant properties of hydrolysates have been investi-
gated and have been demonstrated by the hydrolysis of several
proteins by gastrointestinal enzymes or by acid hydrolysis. The
exact mechanism of antioxidant activity is not well understood, but
several studies show that hydrolysates are lipid oxidation inhibitors
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ion activity (Qian, Jung, & Kim, 2008; Rajapakse, Mendis, Jung, Je, &
Kim, 2005). According to Moosman and Behl (2002), hydrolysates
with a high degree of hydrolysis have a higher amount of lowe
molecular-weight peptides, and thus higher potential for oxidation
inhibition, compared to hydrolysates with a low degree of
hydrolysis.
The antioxidant properties of peptides are reported for their
composition, structure, and hydrophobicity. The amino acids
tyrosine, tryptophan, methionine, lysine, cystine, and histidine are
examples that may act as antioxidants because they have aromatic
residues that donate protons to free radicals. The antioxidant ac-
tivity of peptides containing histidine is related to the ability of
donating hydrogen and ability of chelating metal ions from the
imidazole group (Rajapakse et al., 2005). In addition, as described
by Qian et al. (2008), the SH group in cysteine has an important
antioxidant activity due to direct interaction with the radicals.
Fish are a protein source rich in essential amino acids (lysine,
methionine, cystine, threonine, and tryptophan). The ﬁsh muscle
proteins are made up of several groups of proteins: the fraction
forming the sarcoplasm, which performs biochemical functions in
the cells; myoﬁbrillar proteins of the contractile system; and con-
nective tissue proteins (stromal proteins), mainly responsible for
the integrity of muscles. In addition to their functional, techno-
logical, and nutritional properties, some ﬁsh proteins may exhibit
antioxidant activity, which is associated with certain bioactive
peptides present in protein sequences. Qian et al. (2008), who used
ﬁsh proteins and proteolytic enzymes, obtained peptides with
excellent free-radical scavenging activity that are potent lipid per-
oxidation inhibitors and can be used in food preservation.
The encapsulation of compounds protects a sensitive substance
within the capsule, physically isolating it from the external envi-
ronment. This barrier can provide protection against various agents,
such as oxygen, water, and light, allows for a controlled release of
the substance, and prevents contact with other components in a
mixture. One of the beneﬁts of encapsulation is the ability to control
the release of chemical compounds incorporated and deliver them
to a speciﬁc target at an appropriate time. The controlled release of
ingredients can improve the efﬁciency of food additives and ensure
optimal dosage. Antioxidant encapsulation can be used to protect
the nutritional and sensory quality of food and/or to protect the
body against chronic diseases related to aging. In general, antioxi-
dants are subject to degradation and, when administered by the
body in their free form, they can not pass through the cell mem-
branes and are rapidly eliminated in the circulation (Mozafari et al.,
2006). The use of liposomes has been studied in the encapsulation
of proteins and other food ingredients and different methods for
preparation of liposomes have been proposed in the literature.
Thus, depending on the method and on the characteristics of the
sample, several types of structures can be designed with different
features and encapsulation efﬁciencies. Therefore, the encapsula-
tion of protein hydrolysates can protect its antioxidant activity until
its release in the food or in the human body.
The biological activity of the peptides can be used in food pres-
ervation by incorporating these peptides into food products or
biodegradable packaging. This incorporation can be done through
encapsulated materials for the antioxidant activity to remain active
and controlled throughout the shelf life of the product. The high
protein content in ﬁshwaste has encouraged studies on the recovery
of these proteins in the form of isolated and hydrolysed proteinwith
excellent functional properties. Whitemouth croaker (Micropogonias
furnieri) is a ﬁsh of low commercial value which can potentially be
used in the production of protein hydrolysates. Based on this, the
objective of this study was to produce encapsulated protein hydro-
lysates fromcroakermuscleand thebyproductof its industrialization.2. Materials and methods
2.1. Material
Whitemouth croaker (M. furnieri) ﬁsh captured in southern
Brazil were provided by Pescal Industry in Rio Grande, Brazil. The
ﬁsh were washed in chlorinated water (5 mg/kg) at 4 C and sub-
sequently ﬁlleted to separate the muscle. After these operations,
the guts were removed and the carcasses were processed in ameat/
bone separator (High Tech, model HT250, Chapecó, Brazil) to obtain
the byproduct. The raw materials (muscle and byproduct) were
placed in plastic containers and stored in a freezer at 18 C.
2.2. Enzymatic hydrolysis of croaker proteins
In order to obtain themuscle protein hydrolysate (MPH) and the
byproduct protein hydrolysate (BPH), the croaker muscle and the
byproduct were subjected to a hydrolysis reaction with microbial
protease for obtaining protein hydrolysates. The enzyme used in
the reactionwas Flavourzyme 1000L (enzyme of microbial origin),
provided by Novozymes Latin America Ltda, at a 1:5 substrate/
buffer ratio, while the other reaction conditions were: 2 g/100 g
enzyme/substrate, pH 7, and 120 min of reaction at 50 C. Fla-
vourzyme 1000L is an exopeptidase with an activity of 1 LAPU/g.
An LAPU (leucine aminopeptidase unit) is the amount of enzyme
which hydrolyses 1 mmol of leucine-r-nitroanilide per minute. The
hydrolysates were inactivated by heating in a water bath at 95 C
for 15min and then freezing at80 C for 24 h in an ultrafreezer for
subsequent lyophilisation.
2.3. Hydrolysate encapsulation
The encapsulation process of hydrolysates in the form of lipo-
somes was carried out through the lipid ﬁlm hydration method, as
described by Malheiros, Micheletto, Silveira, and Brandelli (2010).
The source of lipids used to prepare the liposomes was puriﬁed
phosphatidylcholine. In order to obtain puriﬁed phosphatidylcho-
line, the wall material of the capsules, crude soy lecithin, was pu-
riﬁed according to the method described by Mertins, Sebben,
Schneider, Pohlmann, and Silveira (2008). First, 1 g of phosphati-
dylcholine was dissolved in 10 mL of chloroform in a 250 mL glass
ﬂask. After its complete dispersion, the organic solvent was
removed in a rotary evaporator at 50 C until the formation of a
lipid ﬁlm deposited on the walls of the ﬂask. The chloroform traces
were removed by storing the glass ﬂask for 18 h in a vacuum
desiccator at room temperature. The resulting lipid ﬁlm was
dispersed into 20 mL of phosphate buffer pH 7.0, 0.2 mol/L con-
taining 0.2 g of lyophilised hydrolysate. Themixture in the ﬂaskwas
subjected to heating at 60 C for 3 min and slow stirring so the
dispersion did not form foam. After that, the liposomes underwent
rapid stirring in a vortex for 1 min, were left to stand for 3 min, and
ﬁnally heated at 60 C for 2 min; this operation was repeated 3
times. After this step, the suspension was subjected to 10 cycles of
sonication for 1 min and kept in cold water for 3 min, using an
ultrasonic bath (USC-800, Unique Group). A control was performed
under the same encapsulation process conditions, but with no
hydrolysate sample, called control capsule.
2.4. Degree of hydrolysis (DH)
The DH was determined at intervals of zero, 30, 60, 90, and
120 min. An aliquot was removed, mixed with trichloroacetic acid
(TCA 6.25 g/100 g) to inactivate the enzymes and subjected to
ﬁltration. The ﬁltrate was used to determine the concentration of
soluble proteins. The degree of hydrolysis was calculated as the
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by the Kjeldahl method (AOAC, 1997) and the amount of soluble
proteins calculated by the method of Lowry, Rosenbrough, Farr, and
Randall (1951).
2.5. Particle size and polydispersity
To calculate the average particle size and polydispersity, the
dynamic light scattering technique was used (Malvern 4700MW,
model Spectra-physics 127) according to the method described by
Teixeira, Santos, Silveira, and Brandelli (2008) at a wavelength of
632.8 nm, coupled to a BI-200M version 2.0 goniometer and BI-
9000AT digital correlator from Brookheaven Instruments. Poly-
dispersity evaluates the size distribution of particles, showing the
suspension’s degree of homogeneity. The liposomes were ﬁltered
through 0.45 mmpaper ﬁlter and two drops of the sample dissolved
in 8mL of phosphate buffer pH 7.0 0.2mol/L were used for analyses.
2.6. Encapsulation efﬁciency
The encapsulation efﬁciency, i.e., the mass of liposome-
encapsulated protein hydrolysate, was assessed through the in-
direct method. First, 0.5 mL of the liposomes was placed in a
centrifuge tube with 1 mL of acetone, since phosphatidylcholine
is insoluble in this solvent. The samples were centrifuged at
5000 g for 30 min at 3 C, separating into two phases. The su-
pernatant containing the non-encapsulated sample was with-
drawn and placed in an oven at 60 C until complete evaporation
of the solvent. The remaining dried material was resuspended
with 5 mL of distilled water and the protein concentration was
determined through method by Lowry et al. (1951), indirectly
calculating the amount of non-encapsulated sample which was
solubilized in acetone. A 0.5 mL aliquot of the initial sample was
withdrawn and 1 mL of 0.06 g/100 g Triton was added to deter-
mine the total protein in the sample. The material was then ho-
mogenized in a vortex (Phoenix AP56) until complete
solubilization of phosphatidylcholine. The encapsulated material
was calculated by the weight difference between the total and
non-encapsulated material. The encapsulation efﬁciency was
calculated by ratio between the amount of encapsulated material
and the total weight.
2.7. Capsule suspension stability
The suspension stability of the capsules was evaluated through
zeta potential using the equipment Zetasizer Nanoseries Nano-Z
(Malvern Instruments) at 20 C and 90 angle. The suspensions
were stored at 4 C, protected from light and oxygen.
2.8. Capsule transmission electron microscopy (TEM)
The morphology of the capsules containing muscle and
byproduct hydrolysates was evaluated in a Zeiss- EM900 trans-
mission electron microscope (TEM). The sample was ﬁxed with
Karnovsky’s ﬁxative. Liquid samples were centrifuged at 8944  g
for 10 min, the supernatant was removed and the ﬁxer was added
and stirred by vortexing. The material was removed from the
ﬁxative solution and placed in pH 7.2, 0.2 mol/L sodium cacodylate
buffer (1 mL/sample). Thereafter, the second ﬁxing was taken,
which was placed in osmium tetroxide for 2 h. The material was
successively subjected to dehydration in ethanol (30, 50, 70, 90, 95,
and 100 mL/100 mL) and impregnated in epoxi resin. The samples
were cut into slides for evaluation in the transmission electron
microscope.2.9. Capsule thermal properties
The thermal properties of the capsules were determined using
differential scanning calorimetry (Shimadzu DSC 60, TA In-
struments, New Castle, USA). Samples (approximately 2.5 mg, dry
basis) were weighed directly in an aluminium pan with distilled
water. The panwas hermetically sealed and then heated from 40 to
200 C at a rate of 10 C/min. An empty pan was used as reference.
The temperature at the onset (To), the temperature at peak (Tp), the
temperature at the end (Tf), and the enthalpy (DH) were deter-
mined. The temperature range was calculated as TfeTo.
2.10. Capsule Fourier transform infrared (FTIR) spectroscopy
FTIR spectra of the capsules were obtained using a Fourier
transform infrared (FTIR) spectrometer (Prestige-21, Shimadzu,
Japan), in the region of 4000e400 cm1. Pellets were created by
mixing the sample with KBr at a ratio of 1:100 (sample:KBr). Ten
scans were collected at a resolution of 4 cm1.
2.11. Antioxidant activity by the linoleic acid peroxidation
inhibition method
The lipid peroxidation inhibition activity of hydrolysates and
capsules was measured in a linoleic acid emulsion system accord-
ing to the method of Osawa and Namiki (1985) with some modi-
ﬁcations. In short, the sample (5.0 mg), standard a-tocopherol, or
vitamin C was dissolved in 10 mL of 50 mmol/L phosphate buffer
(pH 7.0), and added to a solution of 0.13 mL linoleic acid and 10 mL
of 99.5 g/100 g ethanol. Themixturewas homogenized and the ﬁnal
volume was adjusted to 25 mL with deionized water. A control
reaction was prepared using 50 mmol/L phosphate buffer (pH 7.0).
The mixture was incubated in screw-cap tubes at 40  1 C in the
dark. The degree of linoleic acid oxidation was measured after
seven days. A 0.1 mL aliquot of the incubated solution was mixed
with 4.7 mL of 75 mL/100 mL ethanol, 0.1 mL of 30 g/100 g
ammonium thiocyanate, and 0.1 mL of 0.02 mol/L ferrous chloride
in 3.5 mL/100 mL hydrochloric acid. After 3 min, the degree of
colour development, which represents the oxidation of linoleic
acid, was measured by reading the absorbance at 500 nm on a
spectrophotometer (Biospectro UV, SP-22, Brazil) and calculated
according to Eqn. (1).
inhibition ð%Þ ¼½1ðsample absorbance=control absorbanceÞ
100
(1)
2.12. Statistical analysis
Analytical determinations for the samples were performed in
triplicate, and standard deviations were reported, except for the
results of thermal properties. A comparison of the means was
ascertained by Tukey’s test at 5% signiﬁcance level by analysis of
variance (ANOVA) using the software Statistica 7.0.
3. Results and discussion
3.1. Degree of hydrolysis
The extent of protein degradation by protease was measured by
assessing the degree of hydrolysis (DH), which is the most widely
used indicator to compare different protein hydrolysates. According
to preliminary tests, the degree of hydrolysis of the proteins was
evaluated at 30, 60, 90, 120, and 150 min of reaction and it was
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remained constant. Therefore the production of hydrolysates was
obtained at 120min of reaction. The degree of hydrolysis at 120min
for muscle proteins (28.5%) did not differ statistically from the
degree of hydrolysis of byproduct proteins (27.0%). Thiansilakul
et al. (2007), who produced protein hydrolysates from Decapetrus
maruadsi with the enzyme Flavourzyme and 60 min of reaction,
found higher values for degree of hydrolysis of proteins with
average of 60%. The difference in the values of degree of hydrolysis
between different raw materials can be related to the arrangement
of amino acids present in the protein, and the different enzyme
activity.
According to Vioque, Clemente, Pedroche, Yust, and Millán
(2001), hydrolysates can be categorized into three main groups
based on their degree of hydrolysis, which determines their
application: hydrolysates with low DH improve the functional
characteristics of proteins, hydrolysates with average DH are
generally used as ﬂavourings, and hydrolysates with high DH are
used as nutritional supplements and in special diets in medicine.
Vioque et al. (2006) classiﬁed products depending on the degree of
hydrolysis as partially hydrolysed (DH < 10%) and highly hydro-
lysed (DH> 10%). Therefore, the products obtained in this study are
considered highly hydrolysed and can be used in foods for nutrient
availability and as bioactive compounds.
3.2. Encapsulation efﬁciency, size, polydispersity, and stability of
the capsules
Table 1 shows the results of encapsulation efﬁciency, average
particle size, polydispersity and stability of the capsules in the form
of liposomes from muscle and byproduct hydrolysates. These data
were compared with the control capsule (without sample). The
capsules, also known as liposomes, showed high encapsulation
efﬁciency, with no statistical differences between the samples from
muscle and byproduct (Table 1). The capsules from croaker muscle
and byproduct hydrolysates showed an encapsulation efﬁciency
higher than that found byWere, Bruce, Davidson, andWeiss (2004),
who used the lipid ﬁlm hydration method and sonication for
encapsulation of an antimicrobial peptide (nisin) and obtained
encapsulation efﬁciency of approximately 54%.
The choice of encapsulation method must ensure molecule
stability and the retention of its biological activity, because there is
great difﬁculty in choosing a system nucleus and capsule wall that
enables a suitable encapsulation efﬁciency. In accordance with the
method used in this study, encapsulation by liposomes has been
widely studied by researchers in the healthcare area due to their
potential use as drug coating surrounding bioactive macromole-
cules (Malheiros et al., 2010).
Gómez-Hens and Fernández-Romero (2005) classiﬁed the li-
posomes according to their structure into giant unilamellar vesiclesTable 1
Average particle size, polydispersity, encapsulation efﬁciency and suspension sta-
bility as measured by zeta potential of the capsules obtained from croaker protein
hydrolysates.
Samplea Average
size
(nm)
Polydispersity
index
Encapsulation
efﬁciency (%)
Zeta potential
(mV)
Control capsule 208.1b 0.228b e 5.8a
Muscle hydrolysate
capsule
266.8a 0.298a 80.4a 5.5a
Byproduct hydrolysate
capsule
263.9a 0.197b 79.3a 2.2b
a Data in the same column with different letters are signiﬁcantly different
(p  0.05).(>1 mm), multilamellar vesicles (>400 nm), large unilamellar ves-
icles (80 nme1 mm) and small unilamellar vesicles (20e80 nm). The
average size of the hydrolysate capsules did not differ, but were
higher than the control capsule that was made only with the wall
material (Table 1). The size of the capsules is related to various
factors such as the stirring speed used in the encapsulating process,
composition, concentration, and type of polymer present in the
formulation (Moinard-Chécot, Chevalier, Briançon, Beney, & Fessi,
2008).
The polydispersity index value found for the capsules was
approximately 0.2 (Table 1), which indicates the presence of
monodisperse particle populations or a narrow size range. The low
polydispersity value indicates the homogeneity in particle size
distribution. The capsule containing MPH showed higher poly-
dispersity compared with the capsule of BPH (Table 1). Changes in
the distribution of their diameters may indicate a tendency to
particle aggregation and sedimentation in the system, which did
not happen in this study.
The suspension stability of the capsules was evaluated by the
zeta potential of the MPH and BPH capsules. Almost all particles
in contact with a liquid acquire an electric charge on their surface.
The electric potential at the shear plane is called zeta potential.
This is an important and useful indicator for predicting and
controlling the stability of lipid capsules. The lipid capsules have a
negative surface charge due to the negative charge of the phos-
pholipid molecules (Manconi et al., 2003). But the zeta potential
can be inﬂuenced by different factors such as particle composi-
tion, the dispersing environment, pH, and ionic strength in the
solution.
The zeta potential had negative values (Table 1), allowing to
keep the particles away thereby avoiding the formation of aggre-
gates. The MPH capsules showed higher zeta-potential modulus as
compared to BPH capsules, thus indicating increased stability
(Table 1). The relatively high values of zeta-potential modulus are
important for good physical and chemical stability of formulations,
because the repulsive forces tend to prevent aggregation due to
incidental collisions of adjacent particles. According to Mohanraj
and Chen (2006), nanoparticles that have zeta potential values
near 30mV have good colloidal stability in solution. The values of
the zeta potential in the range of 2.2 and 5.8 (Table 1) indicate
low stability of the particles.3.3. Capsule transmission electron microscopy (TEM)
TEM allows for a qualitative understanding of the internal
structure, spatial distribution, and dispersion of the particles within
the polymer matrix, and views of the defect structure through
direct visualization. Fig. 1 shows the micrographs of encapsulated
and non-encapsulated hydrolysates. Fig. 1a is the external surface
of the control capsule, which has no sample inside. Based on Fig. 1b
and c, it can be seen that the capsules are spherical and that they do
contain material inside. The encapsulation can be seen by
comparing the empty liposomes (Fig. 1a) and MPH and BPH lipo-
somes (Fig. 1b and c, respectively).
The micrograph of BPH liposome (Fig. 1c) shows a more ho-
mogeneous dispersion size when compared with the MPH lipo-
some (Fig. 1b), this statement can be related to the results of
polydispersity because the BPH liposomes showed lower poly-
dispersity index as compared to the MPH liposomes (Table 1).
In the micrographs of non-encapsulated hydrolysates (Fig. 1d
and e) there is a small amount of spherical particles, as these
samples were not subjected to the encapsulation process, we sug-
gest that these particles are fat globule as lipid residue present in
the protein hydrolysates.
Fig. 1. TEM of the control capsule (a), muscle hydrolysate capsule (b), byproduct hydrolysate capsule (c), non-encapsulated muscle hydrolysate (d), and non-encapsulated byproduct
hydrolysate (e).
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The thermal properties of MPH and BPH capsules are shown in
Table 2. The DSC technique is very important in the physical char-
acterization of particles since it provides information about their
crystallinity. It is known that the degree of crystallinity of a particleis extremely important because it will affect encapsulation efﬁ-
ciency, the release rate of the active compound, and the release of
the active compound during the storage process. The DSC analysis
also provides the fusion temperature and enthalpy of particles. The
encapsulated hydrolysate showed high values of enthalpy (Table 2).
According to Attama, Schicke, and Muller-Goymann (2006), a high
Table 2
Thermal properties of capsules obtained from croaker protein hydrolysates.
Samplea To (C) Tp (C) Tf (C) DT (TfTo) DH (J/g)
Control capsule 186.3 187.7 191.5 5.2 52.6
Muscle hydrolysate capsule 177.5 179.4 185.5 8.0 118.2
Byproduct hydrolysate capsule 166.6 172.3 180.6 13.9 124.8
a To: onset temperature; Tp: peak temperature; Tf: ﬁnal temperature; DH:
gelatinisation enthalpy; DT: gelatinisation temperature range.
Table 3
Wavenumber (n in cm1) of spectra of encapsuled hydrolysates by FTIR analysis.
Stretching Control capsule MPH capsulea BPH capsuleb
PO2 1082 1082 1084
CH2 2852 2852 2850
C]O 1645 1637 1656
CH3 2924 2924 2922
OH 3440 3433 3439
NþCH3 989 989 991
a MPH: muscle protein hydrolysate.
b BPH: byproduct protein hydrolysate.
E. da Rosa Zavareze et al. / LWT - Food Science and Technology 59 (2014) 841e848846value of melting enthalpy suggests high organization in the crys-
talline reticulum, because the fusion of a highly organized crystal
requires more energy to rupture the forces of cohesion of the
crystalline reticulum than the fusion of a slightly ordered or
amorphous crystal. Moreover, those authors reported that through
this technique it is possible to observe the crystallization behaviour
of the particles, which inﬂuences whether or not the active com-
pounds will be expelled.
The control capsule, which contains only phosphatidylcholine,
had a higher melting temperature (187.7 C), but showed a lower
melting enthalpy when compared with the hydrolysate capsules
(Table 2). Marcato (2009) reported that in testing the release ki-
netics it is possible to evaluate if a compound in contact with the
lipid system in an aqueous environment is able tomigrate or diffuse
through the solid nanoparticles and dissolve into the lipid phase. If
such migration occurs, it is detected by a change in the shape of a
calorimetric peak due to the increased amount of the compound
within the particles. This behaviour is seen in Fig. 2, which show
peaks in different ways, i.e., the peak of the control capsule was
narrower when compared with the peaks from the MPH capsules
and the BPH capsules. The ﬁgures also show that the values of
temperature difference (DT) were lower than those of the control
capsule (Table 2). This change in peak shape is due to the presence
of the active compounds within the capsules.
3.5. Capsule Fourier transform infrared (FTIR) spectroscopy
The capsules were analysed by absorption spectroscopy in the
infrared region in order to verify the presence of interaction be-
tweenphosphatidylcholine andhydrolysates (Table 3). FTIR analysis
was used to monitor small changes in the structure of the lipid and
active compound by analysing the frequency, intensity, and changes
in the bandwidth of the different vibrational modes that represent
the acyl chains, the interfacial region, and the surface region.Fig. 2. DSC curves of the control capsule (Control), muscle hydrolysate capsule (MPH),
and byproduct hydrolysate capsule (BPH).In the liposome, an orientation occurs of the lipophilic part to
themiddle of the lipid bilayer and the polar part is directed towards
the inside of the capsule and to its external surface. Theoretically,
the FTIR technique measures the asymmetric axial stretching of the
phosphate group’s (PO2) double bond, the axial stretching of the
carbonyl group (C]O), and the axial stretching of the CH2 groups of
liposomes (Toyran & Severcan, 2003).
Table 3 shows the bands present in the spectra and that are
speciﬁc for each functional group of the capsules. The Fig. 3 pre-
sents the FTIR spectra of control capsule and capsules containing
protein hydrolysate. The capsules exhibited bands near 3440 cm1
(Table 3), characteristic of OH stretch. Ferraresi, Ferreira, Silva, and
Neto (2012) also reported that, in the ﬁrst part of spectra, various
signals observed are due to intense OH and NH vibrations, mole-
cules that are hydrogen bonded with each other (broader band),
and those that do not have this type of interaction (acute bands).
According to Bai et al. (2011), the vibration frequency of the CH2
stretching reﬂects the structural information about the interior of
the lipid bilayer of the liposome. There was a shift of the band at
2852 cm1 which represents stretching of the CH2 of the BPH
capsule to 2850 cm1, demonstrating that the peptides had an
inﬂuence in the interior of the bilayer capsules. Thus, the results
obtained in this study suggest an effective ionic complexation
between phosphatidylcholine and peptides from protein
hydrolysates.
It is observed that the stretching of the choline (NþCH3) group,
present in the polar part of phosphatidylcholine, had a band shifted
from 989 cm1 to 991 cm1 in the BPH capsule, which indicated the
presence of peptides in the polar region of phosphatidylcholine, i.e.,
at the region within the liposome. However, it did not affect theFig. 3. Spectra of the control capsule (Control), muscle hydrolysate capsule (MPH), and
byproduct hydrolysate capsule (BPH) by FTIR analysis.
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of the peak of the choline group was conﬁrmed with the band at
949 cm1 and was shifted to 986 cm1 after the molecules interact
with the surface of the carboxymethyl group of phosphatidyl
choline.
The frequency of the phosphate group is useful to monitor the
hydration status of the polar groups of phospholipids. An increase
in frequency will correspond to the dehydrated phosphate group,
while a decrease in frequency corresponds to the hydrous phos-
phate group (Toyran & Severcan, 2003). The frequency of this band
determines the presence or absence of hydrogen bonds between
the phosphate group and the hydrogen atoms of water or biological
macromolecules (Kan-Zhi et al., 1996).
In BPH capsules, a shift from 1082 cm1 to 1084 cm1 was
observed in the band of phosphate from the phosphatidylcholine
grouping (Table 3). There was a reduction in peak intensity (FTIR
spectra) of the phosphate grouping of capsules containing protein
hydrolysate compared to the control capsule. The absorption of the
stretching vibration of the C]O band shifted from 1645 cm1 to
1637 cm1 in theMPH capsule and to 1656 cm1 in the BPH capsule
(Table 3) and reduced intensity after encapsulation. According to
Bai et al. (2011), this shift of the bands of the C]O stretching in-
dicates interactions with hydrogen bonds between the carbonyl
region of the liposome bilayer and the active compound, which in
this case are peptides. The FTIR spectra indicate interactions of the
peptides contained in the hydrolysates with the C]O and PO2
groups of phosphatidylcholine, indicating the location of these
peptides in the lipid polar region, possibly forming hydrogen
bonding with the PO2 group.
3.6. Antioxidant activity of hydrolysates and capsules
Protein hydrolysates produced from the muscle and byproduct
with the same protease and under the same reaction conditions
may have peptides of different sizes and different amino acid se-
quences. The antioxidant activity of hydrolysates was determined
using the method of linoleic acid peroxidation inhibition method.
The measurement of lipid peroxidation inhibition is calculated
by measuring the inhibition of lipid oxidation in a system. Hydro-
peroxides generated during linoleic acid oxidation react with
ferrous sulphate, producing ferric sulfate and later, with the addi-
tion of ferric thiocyanate, forms a blood-red coloured complex
detected at 500 nm. After the reaction starts, the oxidation process
becomes autocatalytic and only ends when the reserve of unsatu-
rated fatty acids and oxygen is depleted (Halliwell & Gutteridge,
2007, pp. 268e340).
As shown in Table 4, the linoleic acid oxidation was inhibited by
the protein hydrolysates and by the encapsuled hydrolysate. MPH
and BPH showed no signiﬁcant difference in their antioxidant ac-
tivities, as well as the MPH and BPH capsules. They did not differ
signiﬁcantly regarding the inhibition of a-tocopherol. However,Table 4
Lipid peroxidation inhibition of the hydrolysed, encapsulated hydrolysed, a-toco-
ferol and vitamin C.
Samplea Lipid peroxidation inhibition (%)
Muscle hydrolysate 27.0bc
Byproduct hydrolysate 31.9b
Control capsule 8.0d
Muscle hydrolysate capsule 22.2c
Byproduct hydrolysate capsule 21.6c
a-tocoferol 25.7bc
Vitamin C 43.2a
a Data in the same column with different letters are signiﬁcantly different
(p  0.05).vitamin C showed the highest inhibition of linoleic acid oxidation
compared with the other samples. For comparison purposes, a
control containing only the wall material of the capsules was also
performed. If the lipid peroxidation inhibition from MPH and BPH
capsules is subtracted from the inhibition value of the control
capsule, inhibition values of 14.2% and 13.6%, respectively, are ob-
tained. These values are lower than those of MPH (27.0%) and BPH
(31.9%) (Table 4) due to the low proportion of protein hydrolysate as
the nucleus of the capsule when compared with the amount of wall
material (phosphatidylcholine), because one gram of wall material
contains only 0.2 g of hydrolysate.
Centenaro, Mellado, and Prentice-Hernández (2011) found
higher values in a study that evaluated linoleic acid oxidation in-
hibition by protein hydrolysates from ﬁsh and chicken bones using
different proteases (Flavourzyme, a-chymotrypsin, and trypsin).
Those authors concluded that, among the ﬁsh bone hydrolysates,
those hydrolysed with Flavourzyme had the highest inhibition
(77.3%) after 7 days of evaluation and, among the chicken bone
hydrolysates, the ones hydrolysed with Flavourzyme also had the
highest inhibition power (61.6%). According to that study, such re-
sults indicate that these hydrolysates might contain antioxidant
peptides.4. Conclusion
It was possible to develop capsules using phosphatidylcholine as
wall material and protein hydrolysate as the active compound. The
capsules exhibit high encapsulation efﬁciency at approximately
80% and the FTIR analysis shows that there was an effective ionic
complexation between phosphatidylcholine and peptides present
in the hydrolysates. Moreover, the capsules maintained the anti-
oxidant activity of the hydrolysates.
The protein hydrolysates produced from croaker muscle and its
industrialization byproduct showed similar antioxidant activity,
close to the activity of a-tocopherol, indicating a potential use for
the production of bioactive compounds from raw material of low
commercial value.References
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